Risk factor
Very poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E.
Target Price
The average target price of COG.L is 55 and suggests 27% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell